![]() |
市場調查報告書
商品編碼
2034897
全球周邊血管內超音波(IVUS)市場:規模、佔有率和趨勢分析(2025-2032):MedCorePeripheral Intravascular Ultrasound (IVUS) Market Size, Share & Trends Analysis | Global | 2025-2032 | MedCore |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球周邊血管內超音波市場報告(至2032年)
2025年,全球周邊血管內超音波市場規模超過2.4億美元。預計到2032年,該市場將以6.9%的複合年成長率成長,達到3.83億美元。
周邊血管內超音波(IVUS)用於在介入手術過程中提供血管內部的即時影像。這使醫生能夠更準確地評估血管結構,輔助治療方案的製定,並最佳化器械放置位置。
推動市場成長的因素包括:靜脈治療中 IVUS 的日益普及、周邊介入治療的興起,以及高解析度影像技術和微型化導管系統的不斷發展。
血管內主機的高昂部署成本以及解讀IVUS影像的學習曲線限制了其市場滲透率。儘管IVUS能夠提供寶貴的術中指導,但其應用取決於醫療機構的預算、醫生的培訓以及臨床醫生對影像平台的熟練程度。
市場概覽
全球血管內超音波(IVUS)市場包括用於周邊血管手術的一次性IVUS導管和相關主機系統。 IVUS可在介入治療過程中提供血管內部影像,幫助臨床醫師觀察血管結構、制定治療策略並改善手術效果。
周邊血管內超音波(IVUS)在外部影像無法提供足夠細節的複雜病例中特別有用。透過獲取血管內部影像,IVUS 可以幫助醫生更直接地評估血管大小、斑塊負荷、閉塞情況、病變特徵和器械位置。
市場主要趨勢是高解析度成像技術和微型導管系統的發展。這些進步能夠提高周邊血管介入手術的可視性、導航精度和決策準確性。隨著導管設計的不斷改進,血管內超音波(IVUS)將能夠適應更廣泛的血管直徑和手術需求。
此外,靜脈領域的應用也正在形成市場。飛利浦主要企業,正積極將IVUS應用於靜脈治療領域。繼VIDIO試驗取得正面成果後,IVUS已與下腔靜脈、髂總靜脈、髂股靜脈和股總靜脈的閉塞手術緊密結合。
市場促進因素
靜脈治療中血管內超音波(IVUS)的應用是周邊血管內超音波市場最強大的驅動力之一。飛利浦將其血管內超音波產品與靜脈治療流程相結合進行推廣,從而推動血管內超音波成為深部靜脈介入治療領域領先的影像工具。目前,血管內超音波在深部靜脈治療的應用率已超過50%,預計靜脈治療將繼續推動市場強勁成長。
人口因素也是推動周邊血管介入治療需求成長的因素之一。 65歲及以上族群周邊動脈疾病(PAD)的盛行率正在上升。隨著全球人口老化,PAD的盛行率預計將繼續攀升,這將導致周邊血管介入治療數量的增加,並促進血管內IVUS導管的銷售成長。
高解析度成像技術和微型導管系統的持續發展也拓展了周邊血管內超音波的應用範圍。更清晰的視野和更靈活的導管操作性使醫生能夠在介入手術過程中做出更精準的決策。這些改進在複雜的周邊血管病變中尤其重要,因為準確的血管評估和治療導管的最佳放置位置會顯著影響治療效果。
市場限制
資本投資成本仍是推廣應用的一大障礙。血管內超音波(IVUS)系統需要一次性IVUS導管和IVUS主機。常見的IVUS主機包括飛利浦的Core®和Core® Mobile平台。對於注重成本的醫療機構而言,主機的初始投資可能會限制IVUS系統的推廣應用,並降低導管單元的銷售量。
圖像解讀也面臨挑戰。血管內超音波(IVUS)影像可能顆粒感較強,且不如其他影像技術直覺,因此未經訓練的使用者難以解讀。醫生要想在日常工作中熟練使用IVUS,通常需要接受訓練並反覆練習。
雖然培訓過程本身並不難,但在實施初期仍構成了一定的障礙。與可能提供更清晰、更直覺影像的新型影像技術相比,如果醫生和醫療機構認為血管內超音波(IVUS)的臨床價值不足以抵消學習曲線和設備成本,那麼在某些情況下,IVUS 的選擇率可能會降低。
市場覆蓋範圍和數據範圍
研究的定量範圍包括市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售量和平均售價。
定性研究範圍包括市場促進因素和限制因素、競爭分析、近期併購、公司簡介、產品系列、主要競爭對手和市場成長趨勢。
本報告包括銷售量、平均售價、治療次數、市場規模、市場成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。
本報告針對每個地區提供市場評估、銷售量分析和平均售價 (ASP) 評估。這使讀者能夠比較成熟市場和新興市場之間的治療需求、定價趨勢、採用模式和競爭趨勢。
本報告旨在幫助用戶了解導管銷售、主機普及率、手術量成長以及醫生偏好如何影響全球周邊血管內超音波(IVUS)市場。市場收入評估是基於銷售量和平均售價,並輔以截至2032年的基於手術量的預測。
目標市場及區隔
周邊血管內IVUS導管市場包括用於在周邊血管手術中產生血管內影像的一次性導管。根據血管大小、入路和臨床需求,這些導管可用於動脈和靜脈手術。
IVUS主機部分包含一個成像平台,可連接至相容的IVUS導管。主機的安裝可能會影響導管的長期使用,因為實施該系統的醫療機構通常會為重複性手術購買一次性導管。
周邊血管內超音波(IVUS)的應用也受到適應症類型的影響。雖然靜脈治療是一個主要的成長領域,但由於人口老化和周邊介入治療數量的增加,周邊動脈疾病的治療仍然十分重要。
每個細分市場都以市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售量和平均售價進行分析。
這種市場細分揭示了設備相容性、臨床適應症、設施投資和醫生培訓如何塑造全球周邊血管內超音波市場的需求。
競爭分析
憑藉其廣泛的導管產品組合和在靜脈適應症方面的強大地位,飛利浦在 2025 年引領了全球周邊 IVUS 市場。該公司提供多種外周IVUS導管型號,包括 Visions® PV .018、Visions® PV .035、Visions® PV .014P 和 Visions® PV .014P RX。
飛利浦也提供 Eagle Eye Platinum 和 Eagle Eye Platinum ST IVUS導管,這些導管可用於冠狀動脈和周邊血管手術。這些導管與飛利浦的 Core® 和 Core® Mobile IVUS主機相容,從而建立了一個整合的導管和主機生態系統。
飛利浦最大的優勢在於其相位陣列(IVUS導管技術。與旋轉式IVUS導管相比,相位陣列設計簡化了操作流程,使術中操作更加便利。此外,飛利浦是唯一一家提供全系列IVUS導管產品的製造商,產品涵蓋0.014英吋、0.018英吋和0.035英吋的周邊IVUS導管。
2025年,波士頓科學公司成為周邊血管內超音波(IVUS導管市場第二大廠商。其市場地位得益於OptiCross18®周邊IVUS導管,該導管與iLab®和POLARIS™系統相容。憑藉其豐富的末梢用器材產品組合和互補的產品線,波士頓科學公司在周邊動脈疾病領域擁有強大的市場地位。
然而,在靜脈市場,飛利浦在導管尺寸範圍方面佔據主導地位,並已建立起更強大的市場影響力,波士頓科學則面臨更大的壓力。隨著靜脈血管內超音波(IVUS)應用的不斷擴展,飛利浦預計將保持強大的競爭力,但波士頓科學的成長將取決於周邊動脈疾病的需求以及其填補導管產品系列空白的能力。
科技和醫療治療的發展趨勢
這些趨勢表明,全球周邊血管內超音波市場正朝著影像品質更高、導管選擇更靈活以及在複雜周邊介入手術中應用更廣泛方向發展。同時,其普及程度仍將取決於醫療機構的投資、主機可用性和醫生的信心。
地區
本報告涵蓋全球調查區域,包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。
iData Research 的《全球周邊血管內超音波(IVUS) 市場報告》旨在幫助製造商、投資者、經銷商和策略團隊了解需求成長點、靜脈和周邊動脈疾病(PAD) 相關手術如何影響 IVUS 的應用,以及導管和主機生態系統如何影響市場表現。該報告提供按手術類型、銷售量、平均售價 (ASP)、市場預測和競爭分析分類的市場模型,以協助制定全球周邊 IVUS 市場規劃。
Global Peripheral Intravascular Ultrasound Market Report to 2032
The global peripheral intravascular ultrasound market was valued at over $240 million in 2025. It is expected to grow at a compound annual growth rate of 6.9%, reaching $383 million by 2032.
Peripheral intravascular ultrasound, also known as peripheral IVUS, is used during interventional procedures to provide real-time imaging from inside the vessel. This allows physicians to better assess vessel structures, support treatment planning, and optimize device placement.
Growth in this market is being driven by rising use of IVUS in venous treatments, increasing peripheral interventions, and the continued development of high-definition imaging technologies and miniaturized catheter systems.
Market adoption remains limited by the capital cost of IVUS consoles and the learning curve associated with interpreting IVUS images. Although IVUS provides valuable procedural guidance, uptake depends on facility budgets, physician training, and clinical comfort with the imaging platform.
Market Overview
The global peripheral intravascular ultrasound market includes disposable IVUS catheters and related console systems used in peripheral vascular procedures. IVUS provides internal vessel imaging during intervention, helping clinicians visualize vessel structure, guide treatment decisions, and improve procedural outcomes.
Peripheral IVUS is especially relevant in complex cases where external imaging may not provide enough detail. By imaging from within the vessel, IVUS can help physicians assess vessel size, plaque burden, obstruction, lesion characteristics, and device placement more directly.
A major trend in the market is the development of high-definition imaging technologies and smaller catheter systems. These improvements support better visualization, improved navigation, and more informed decisions during peripheral interventions. As catheter designs improve, IVUS can be used across a broader range of vessel sizes and procedural needs.
The market is also being shaped by venous applications. Philips, the leading company in IVUS devices, has actively positioned IVUS in connection with venous treatments. Following positive VIDIO trial results, IVUS has become closely associated with procedures involving the inferior vena cava, common iliac, iliofemoral, and common femoral vein obstruction.
Market Drivers
Venous treatment adoption is one of the strongest drivers of the peripheral IVUS market. Philips has marketed its IVUS products alongside venous treatment workflows, helping establish IVUS as a key imaging tool in deep venous interventions. With penetration rates of IVUS use in deep venous treatments already over 50%, venous procedures are expected to support strong market growth.
Demographic factors are also driving demand for peripheral interventions. The prevalence of peripheral arterial disease increases among individuals aged 65 and older. As the global population ages, PAD prevalence is expected to rise, increasing the number of peripheral vascular procedures and supporting higher IVUS catheter unit sales.
The continued development of high-definition imaging and miniaturized catheter systems is also expanding the role of peripheral IVUS. Better visualization and improved catheter navigation allow physicians to make more informed decisions during interventional procedures. These improvements are especially important in complex peripheral cases where accurate vessel assessment and optimized treatment placement can influence outcomes.
Market Limiters
Capital equipment cost remains a major barrier to adoption. An IVUS system requires both disposable IVUS catheters and an IVUS console. Popular IVUS consoles include Philips' Core(R) and Core(R) Mobile platforms. For cost-sensitive facilities, the upfront investment in the console can limit adoption and reduce catheter unit sales.
Image interpretation is another barrier. IVUS images can be difficult for untrained users to interpret because they may appear grainy and less immediately clear than some other imaging methods. Physicians often need training and repeated use before they become comfortable applying IVUS in regular practice.
Although the training process is not considered difficult, it still creates friction during early adoption. Compared with developing imaging techniques that may provide cleaner and more intuitive images, IVUS may become less preferred in some settings if physicians or facilities do not see enough clinical value to justify the learning curve and equipment cost.
Market Coverage and Data Scope
Quantitative coverage includes market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
Qualitative coverage includes market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, leading competitors, and market growth trends.
The report includes unit sales, average selling prices, procedure numbers, market size, market growth trends, market forecasts through 2032, and historical data back to 2022.
For each region, the report provides market valuation, unit analysis, and ASP assessment. This allows readers to compare procedural demand, pricing trends, adoption patterns, and competitive dynamics across mature and emerging markets.
The report is designed to help users understand how catheter unit sales, console adoption, procedure growth, and physician preference affect the global peripheral IVUS market. Market revenue is assessed using unit sales and average selling prices, supported by procedure-based forecasting through 2032.
Markets Covered and Segmentation
The peripheral IVUS catheter market includes disposable catheters used during peripheral vascular procedures to generate intravascular imaging. These catheters are used in both arterial and venous procedures, depending on vessel size, access route, and clinical need.
The IVUS console segment includes imaging platforms that connect with compatible IVUS catheters. Console placement can influence long-term catheter usage because facilities with installed systems are more likely to purchase disposable catheters for recurring procedures.
Peripheral IVUS adoption is also influenced by indication type. Venous treatments are a major area of growth, while peripheral arterial disease procedures remain important due to aging demographics and increasing peripheral intervention volumes.
Each segment is analyzed by market size, market share, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
This segmentation helps show how device compatibility, clinical indication, facility investment, and physician training shape demand in the global peripheral IVUS market.
Competitive Analysis
Philips led the global peripheral IVUS market in 2025, supported by its broad catheter portfolio and strong position in venous indications. The company offers several peripheral IVUS catheter models, including Visions(R) PV .018, Visions(R) PV .035, Visions(R) PV .014P, and Visions(R) PV .014P RX.
Philips also offers Eagle Eye Platinum and Eagle Eye Platinum ST IVUS catheters, which are used in both coronary and peripheral procedures. These catheters are compatible with Philips' Core(R) and Core(R) Mobile IVUS consoles, giving the company a connected catheter and console ecosystem.
A key advantage for Philips is its phased-array IVUS catheter technology. Compared with rotational IVUS catheters, phased-array designs can support a simpler workflow and easier use during procedures. Philips also stands out as the only provider with a comprehensive IVUS catheter range covering 0.014", 0.018", and 0.035" peripheral IVUS catheters.
Boston Scientific ranked second in the peripheral IVUS catheter market in 2025. Its position is supported by the OptiCross18(R) peripheral IVUS catheter, which is compatible with the iLab(R) and POLARIS(TM) systems. Boston Scientific has particular strength in peripheral arterial disease indications due to its broader peripheral device portfolio and complementary products.
However, Boston Scientific faces more pressure in the venous market, where Philips has stronger catheter sizing coverage and a more established position. As venous IVUS use continues to grow, Philips is expected to remain highly competitive, while Boston Scientific's growth will depend on peripheral arterial disease demand and its ability to address catheter portfolio gaps.
Technology and Practice Trends
These trends show that the global peripheral IVUS market is moving toward better image quality, more flexible catheter options, and greater use in complex peripheral interventions. At the same time, adoption will remain tied to facility investment, console availability, and physician confidence.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
The Global Peripheral Intravascular Ultrasound Market Report from iData Research helps manufacturers, investors, distributors, and strategy teams understand where demand is growing, how venous and PAD-related procedures are affecting adoption, and how catheter and console ecosystems influence market performance. It provides procedure-based market models, unit sales, ASPs, market forecasts, and competitive analysis to support planning across the global peripheral IVUS market.